Heron Therapeutics (HRTX) Interest Coverage Ratio Growth (1y) (2013 - 2017)
Heron Therapeutics (HRTX) Interest Coverage Ratio Growth (1y) (2013 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2017 |
-47.99% |
| Dec 31, 2016 |
70.69% |
| Sep 30, 2016 |
42.03% |
| Jun 30, 2016 |
-72.57% |
| Mar 31, 2016 |
-279.59% |
| Dec 31, 2015 |
-343.18% |
| Sep 30, 2015 |
-9.84% |
| Jun 30, 2015 |
-13.69% |
| Mar 31, 2015 |
-9.43% |
| Dec 31, 2014 |
179.26% |
| Sep 30, 2014 |
-39.64% |
| Jun 30, 2014 |
-15.13% |
| Mar 31, 2014 |
55.35% |
| Mar 31, 2013 |
-660.75% |
